MedTrace Logo

Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population

NCT02547701 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-03-08

No results posted yet for this study

Summary

Pediatric patients affected by mild-to-moderate distal subungual onychomycosis (DSO) or affected by white superficial onychomycosis (WSO), due to dermatophytes, will be treated topically with P-3058 nail solution according to the appropriate treatment schedule.

Conditions

  • Onychomycosis

Interventions

DRUG

P-3058

Sponsors & Collaborators

  • Polichem S.A.

    lead INDUSTRY

Principal Investigators

  • Maurizio Caserini, MD · Polichem SA

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • Belgium
  • Germany
  • Italy
  • Latvia
  • Spain

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02547701 on ClinicalTrials.gov